Cellbox Solutions Secures Series A Financing and New Leadership for Global Expansion

Cellbox Solutions GmbH has successfully closed the first tranche of its Series A financing, raising around EUR 3.5 million. The round, led by the digital business angel network Companisto along with existing investors such as NRW.BANK, aims to scale Cellbox’s warm-chain logistics platform internationally. The company plans to use the funding to expand production and sales and explore new application areas, particularly in cell and gene therapy and in vitro fertilization.

Dr. Bernd Muehlenweg joins Cellbox as the new Chief Business Officer and Chief Financial Officer. With over 20 years of experience in the life sciences industry, Dr. Muehlenweg is expected to play a pivotal role in driving the company's international expansion and service portfolio growth. His previous role was Senior Vice President and Global Head of Business Development, Cell Therapy at Evotec.

Cellbox is noted for its portable CO₂ incubators, allowing safe transport of living cells under controlled conditions. The company has over 300 devices in use worldwide, serving key customers in pharmaceutical and biotechnology fields. The recent financing will support Cellbox’s goal to make warm-chain logistics a global standard in the transportation of sensitive biological materials.